The third coronavirus outbreak in the past 20 years, the SARS-CoV-2 pandemic has caused unprecedented morbidity, mortality, and economic disruption. Safe, effective, and deployable SARS-CoV-2 vaccines are urgently needed to mitigate the consequences of the pandemic and protect from future outbreaks. The accelerated response to Covid-19 includes investments in preclinical and clinical testing and manu- facture of multiple vaccine candidates, with efficacy trials in the United States anticipated to start in July 2020.

6th July 2020 • 0 comments
31st March 2020 • 0 comments

Ethical considerations for human infection studies: experiences and perceptions of study participants in Kenya

by M. Njue, P. Njuguna, M. Kapulu, G. Sanga, P. Bejon, V. Marsh, S. Molyneux, D. Kamuya
5th February 2020 • 0 comments
27th November 2019 • 1 comment